Triomics nabs $22M to bring oncology-specific AI to cancer centers
The Series B round was led by Battery Ventures.
The Series B round was led by Battery Ventures.
AegisAI co-founders developed AI agents that quickly analyze each message as a human would, paying attention to small anomalies that even the most elaborate checklist wouldn’t catch.